MedTrace Logo

Biomarkers in Patients With Rhabdomyosarcoma

NCT01466283 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2016-05-19

No results posted yet for this study

Summary

RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is studying biomarkers in patients with rhabdomyosarcoma.

Conditions

  • Sarcoma

Interventions

GENETIC

DNA methylation analysis

GENETIC

fluorescence in situ hybridization

GENETIC

gene expression analysis

GENETIC

reverse transcriptase-polymerase chain reaction

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Caroline Y. Hu, MD · Tomorrows Children's Institute at Hackensack University Medical Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2016-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01466283 on ClinicalTrials.gov